Valkyra Technologies is a United States-based medical technology company founded in 2024 to support frontline responders during the critical first minutes of trauma care. Its mission is to help make emergency decisions faster and more informed, bridging the gap between the point of injury and definitive care. The company develops augmented reality (AR) heads-up display systems and artificial intelligence (AI) decision-support tools that present actionable information, including vital signs, injury visualization, and protocol guidance, within responders’ field of view.

Valkyra aims to enable faster triage, safer interventions, and smoother handoffs to medical teams. Its approach emphasizes secure, interoperable, human-centered technology for life-threatening situations. The multidisciplinary team brings together experience in technology, healthcare, medical devices, diagnostic imaging, clinical research, and operations.

Valkyra is currently in stealth and invites inquiries about procurement, clinical trials, research collaboration, and career opportunities. Its work is guided by a focus on humanity, precision, and resilience, with the goal of giving frontline personnel clearer support when every second matters